According to Soligenix's latest financial reports the company's total assets are $9.79 M. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2022-12-31 | $14.27 M | -46.86% |
2021-12-31 | $26.86 M | 35.08% |
2020-12-31 | $19.89 M | 155.82% |
2019-12-31 | $7.77 M | -25.89% |
2018-12-31 | $10.49 M | 9.86% |
2017-12-31 | $9.54 M | -6.99% |
2016-12-31 | $10.26 M | 38.99% |
2015-12-31 | $7.38 M | 6.22% |
2014-12-31 | $6.95 M | -15.86% |
2013-12-31 | $8.26 M | 75.67% |
2012-12-31 | $4.7 M | -42.79% |
2011-12-31 | $8.22 M | -11.27% |
2010-12-31 | $9.26 M | -1.23% |
2009-12-31 | $9.38 M | 179.07% |
2008-12-31 | $3.36 M | -11.13% |
2007-12-31 | $3.78 M | 168.94% |
2006-12-31 | $1.4 M | -58.28% |
2005-12-31 | $3.37 M | -33.45% |
2004-12-31 | $5.06 M | -18.94% |
2003-12-31 | $6.25 M | 7.09% |
2002-12-31 | $5.83 M | -47.13% |
2001-12-31 | $11.04 M |
Company | Total assets | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $167.55 B | 1,710,141.46% | ๐บ๐ธ USA |
Pfizer PFE | $226.50 B | 2,311,764.56% | ๐บ๐ธ USA |
Sanofi SNY | $139.81 B | 1,426,982.68% | ๐ซ๐ท France |
Onconova Therapeutics ONTX | $27.03 M | 175.97% | ๐บ๐ธ USA |
Athersys ATHX | $7.42 M | -24.18% | ๐บ๐ธ USA |
Teva Pharmaceutical Industries TEVA | $43.47 B | 443,684.17% | ๐ฎ๐ฑ Israel |
Cleveland BioLabs
CBLI | N/A | N/A | ๐บ๐ธ USA |
Emergent BioSolutions
EBS | $1.82 B | 18,509.15% | ๐บ๐ธ USA |